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Objective: To determine reliability, feasibility, and validity of the Doyle Index (DI), a pain score proposed
for osteoarthritis (OA).
Methods: The DI was performed in 260 patients with OA at multiple sites (mean age 64.9 years, 84%
women) by grading pain (0e3) in 48 joints and joint groups by pressure or passive movement. Reliability
and feasibility were determined in a random sample of 18 patients, by examining them twice using four
raters. Intraclass correlation coefﬁcients (ICCs) for intra- and interrater reliability were calculated, as well
as the mean time to perform the DI. Validity was assessed in 260 patients, by correlating DI total scores
and DI scores for the hand and knee/hip joints separately, to the pain and function subscales of the
Australian/Canadian Osteoarthritis Hand Index (AUSCAN) and Western Ontario and McMaster Univer-
sities Osteoarthritis Index (WOMAC), using Spearman’s rank coefﬁcient (r).
Results: In the total population the median (interquartile range) DI score was 11.0 (5.0e19.0). Intra-
observer ICCs [95% conﬁdence interval (CI)] ranged from 0.94 (0.84, 0.98) to 0.97 (0.93, 0.99). Interob-
server ICC was 0.88 (0.77, 0.94). The mean time to perform the total DI was 5.1 min (range 2.4e7.8). DI
total scores as well as scores for the hand and knee/hip joints separately were related to AUSCAN (r range
0.61e0.65) and WOMAC (r range 0.43e0.51), although the level of correlation was moderate.
Conclusion: The DI is a reliable, easy to perform, and validmeasure for OA pain during physical examination
and therefore apromisingadditional outcomemeasurenotonly forOA researchbut also for clinical practice.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction A standardized method to assess pain during physical exami-Osteoarthritis (OA) is a common heterogeneous joint disorder
which may affect any joint, but mostly the hand joints, knees, hips,
and spine. Oftenmultiple joints are affected in a patient. Joint pain is
the primary symptom of OA, accompanied by stiffness and gradual
loss of function. To date only treatment of symptoms is available.
Pain is one of the core outcome measures in the evaluation of
OA1,2. It can be assessed using subscales of standardized question-
naires or a single item global pain Visual Analog Scale (VAS), both
reﬂecting self-reported pain2. In addition, pain can be assessed
during physical examination, whichmay reﬂect a different aspect of
disease. Self-reported pain may incorporate more psychosocial
aspects, whereas pain on physical examination may be less
subjective.to: J. Bijsterbosch, Leiden
gy, C1-R, P.O. Box 9600, 2300
: 31-71-5266752.
sch).
s Research Society International. Pnation is lacking. In 1981 an articular index for the assessment of
joint pain in OA was proposed, the Doyle Index (DI)3. This articular
index is a modiﬁcation of the Ritchie index which is widely used in
rheumatoid arthritis4. The DI includes 48 joints or joint groups for
assessment, based on the pattern of joint involvement in OA. Since
it may evaluate other aspects of pain than questionnaires, it can be
a valuable additional outcome measure in OA. However, its clini-
metric properties have not been investigated yet.
Therefore we determined the reliability, feasibility, and validity
of the DI in patients with OA at multiple sites. Besides its applica-
tion in research, the DI can be used in patient care.Methods
Study design and patient population
The study population consisted of 260 patients participating in
the Genetics ARthrosis and Progression (GARP) study, visiting forublished by Elsevier Ltd. All rights reserved.
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GARP study with familial OA at multiple sites in the hands or in at
least two joint sites being hand, knee, hip, or spine. They were
required to have symptomatic OA in at least one joint site. In case of
one symptomatic OA joint site, structural abnormalities in at least
one other joint site were required. Symptomatic hand OA was
deﬁned according to the American College of Rheumatology (ACR)
criteria6. In the knee, hip, and spine symptomatic OAwas deﬁned as
a combination of symptoms and radiographic OA signs as described
by the ACR criteria7,8. Details on the recruitment and follow-up
have been published elsewhere5,9. The study was approved by the
Medical Ethics Committee.
A random sample of 18 patients was used to determine reli-
ability and feasibility during an additional visit. Using four raters the
DI was performed twice in each patient by each rater, with a 90-min
time interval. The order in which patients were assessed differed
between raters and between the ﬁrst and second scoring. The time
to perform the DI in each patient was measured using a stopwatch.
All raters were familiar with the DI and consensus on how to
conduct the DI was reached in advance.
DI
Using the DI, pain is graded during physical examination in 48
joints or joint groups (Table I) by pressure on the lateral joint
margin or by passive joint movement on a four-point scale: 0¼ no
pain, 1¼ patient complains of pain, 2¼ patient complains of pain
and winces, 3¼ patient complains of pain, winces, and withdraws
joint. The total score ranges from 0 to 144. Joints with prosthesis are
not graded and not included in the score.
Subscores for the hand were calculated by summing the scores
for all hand joints (range 0e72). The same was done for the knee
and hip (range 0e12).
Questionnaires
Self-reported pain and functional limitations were assessed
with the corresponding subscales of the Australian/Canadian
Osteoarthritis Hand Index (AUSCAN) and Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC), assessingTable I
Using the DI pain is graded 0e3 in 48 joints or joint groups by pressure or passive
movement
Joint Method of testing Number of units
DIP IIeV (individually) Pressure 8
PIP IIeV, IP I (individually) Pressure 10
MCP IIeV Pressure 2
MCP I Pressure 2
CMC I Pressure 2
Wrist Pressure 2
Elbow Pressure 2
Shoulder Pressure 2
Acromioclavicular Pressure 1
Sternoclavicular Pressure 1
Cervical spine Movement 1
Lumbar spine Movement 1
Hip Movement 2
Knee Pressure 2
Ankle Movement 2
Talocalcaneal Movement 2
Midtarsal Movement 2
MTP I Pressure 2
MTP IIeV Pressure 2
Total 48
Abbreviations: DIP: distal interphalangeal joints, PIP: proximal interphalangeal
joints, IP-I: ﬁrst interphalangeal joint, MCP: metacarpal joints, CMC-I: ﬁrst carpo-
metacarpal joints, MTP: metatarsal joints.hand and knee and hip, respectively10,11. Using the AUSCAN, pain
and functional limitations are graded on a Likert scale (0¼ none to
4¼ extreme), total scores ranging from 0 to 20 and 0 to 36,
respectively. WOMAC scores range from 0 to 100 since the VAS
format was used.
Statistical analysis
Data were analyzed using SPSS 16.0 (SPSS Inc, Chicago, IL). To
evaluate intra- and interrater reliability intraclass correlation
coefﬁcients (ICCs) with 95% conﬁdence intervals (95% CI) were
estimated using a one-way random analysis of variance (ANOVA)
model and a two-way random ANOVA model for absolute agree-
ment, respectively. Before estimating the ﬁnal ICC it was assessed
whether DI scores within one patient got worse as effect of repet-
itive assessment. In addition, the Bland and Altman method was
used12.
Feasibility was determined by calculating the mean time to
perform the DI for each rater separately and for all raters together.
The relationship between the performance time (dependent vari-
able) and DI scores (independent variable) was determined using
linear regression analysis.
Construct validity was assessed by testing three a priori deﬁned
hypotheses. The ﬁrst was that the DI is positively related to self-
reported pain and function. This was tested by correlating DI scores
to the pain and function subscales of the AUSCAN and WOMAC
using Spearman’s rank correlation coefﬁcient, r, with 95% CI.
Secondly, we determined whether DI hand and knee/hip scores
correlated to pain and function measured with the AUSCAN and
WOMAC, respectively. Finally, we tested whether DI scores
increased with an increasing number of OA joint sites, using the
KruskaleWallis test.
Results
Population description
Patient characteristics are shown in Table II. The median
[interquartile range (IQR)] DI total score was 11.0 (5.0e19.0).
Median (IQR) DI scores for the hand and the knee/hip joints sepa-
rately were 4.0 (2.0e9.0) and 2.0 (0.0e3.0), respectively.
Reliability
Intrarater reliability for the four raters separately was high
(Table III). The average intrarater ICC (95% CI) was 0.95 (0.93, 0.97).
The ICC (95% CI) for interrater reliability was 0.88 (0.77, 0.94). No
effect of repetitive assessment was present, meaning that DI scores
per patient did not increase with a second performance.Table II
Patient characteristics of 260 patients with OA at multiple sites
Age, yrs 64.9 7.2
Women, no (%) 217 (84)
Body mass index, kg/m2 28.3 5.7
Symptomatic OA sites, no (%)
Hand OA 206 (81)
Knee OA 98 (39)
Hip OA 80 (32)
Spine OA 193 (75)
AUSCAN pain (0e20) 7.2 4.8
AUSCAN function (0e36) 13.7 8.8
WOMAC pain (0e100) 28.6 25.8
WOMAC function (0e100) 28.2 24.0
Values are means standard deviation (SD) unless stated otherwise.
Table III
Intrarater reliability for each rater and overall interrater reliability expressed as ICC
and time to perform the DI for four raters in 18 patients with OA at multiple sites
Intrarater reliability,
ICC (95% CI)
Interrater reliability,
ICC (95% CI)
Time, minutes
(mean SD)
Rater 1 0.97 (0.93, 0.99) 0.88 (0.77, 0.94) 4.3 0.8
Rater 2 0.95 (0.88, 0.98) 5.8 1.4
Rater 3 0.94 (0.84, 0.98) 6.0 0.7
Rater 4 0.95 (0.86, 0.98) 4.1 0.3
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systematic differences (not shown). However, from plots for inter-
rater reliability (Fig. 1) it seems that there are some systematic
differences between raters.Feasibility
The mean time to perform the DI for the four raters is shown in
Table III. For all raters together the mean time was 5.1 min (range
2.4e7.8 min). The time to perform the DI was positively related to
the DI total score, meaning that it took more time to perform the DI
in patients with more pain.Construct validity
DI total scores and scores for the hand and the knee/hip joints
separately were related to the pain and function subscales of the
AUSCAN and WOMAC (Table IV). However, the level of correlation
was only moderate. With an increasing number of OA joint sites DI
scores increased. Median (IQR) DI scores for patients with one, two,
three, and four symptomatic OA sites were 7.0 (3.5e13.5), 10.0
(5.0e16.0), 16.0 (9.0e25.0), and 16.0 (7.0e24.0), respectively
(P< 0.01).
Sensitivity analysis in patients without prosthesis (n¼ 203)
showed similar correlations between WOMAC and DI scores. DI
scores for the whole lower extremity showed the same level of
correlation to WOMAC as DI total scores.Fig. 1. BlandeAltman plots showing the differences in DI scores between raters in relation t
the dotted line represents the limits of agreement.Discussion
This study in patients with OA at multiple sites showed that the
DI is a reliable, feasible, and valid measure for pain in OA. Intra- and
interrater reliability were high and on average it took 5 min to
perform the DI. The higher the DI score, the more time it takes to
perform. Patients with more symptomatic joint sites involved had
higher DI scores. The DI is obtained during physical examination
and therefore may reﬂect a different aspect of disease than self-
reported pain, which is supported by the modest strength of
correlation between the DI and self-reported outcome measures.
The favorable clinimetric properties in combination with the
possibility to assess all joints together as well as speciﬁc joint
groups separately, make the DI a valuable additional outcome
measure for OA research and use in clinical practice.
The Outcome Measures in Rheumatology (OMERACT) ﬁlter
identiﬁes three concepts that should be evaluated for a potential
outcome measure: truth (validity), feasibility, and discrimination
(reliability and sensitivity to change)13. In this study sensitivity to
changewas not assessed. However, follow-up data over 2 years from
the GARP study on a modiﬁed DI and self-reported pain measured
with the AUSCAN and WOMAC have been published14,15. Using the
modiﬁedDI the same jointswere assessed, only gradingwas slightly
different. The studies showed that the sensitivity to change of the
modiﬁed DI concerning the hand joints and the knee/hip joints,
expressed by the standardized response mean (SRM), was 0.67 and
0.41, respectively. The sensitivity to change of the AUSCAN and
WOMAC pain subscale was lower with SRMs of 0.25 and 0.15,
respectively. Because the modiﬁed DI is very similar to the DI, we
feel that the sensitivity to change of theDIwill be comparable, being
better than established outcome measures for pain in OA.
The DI is hand-oriented since half of the assessed joints belong to
the hand. We have shown that the DI subscores for separate joint
groups have comparable correlations with self-reported outcome as
the DI total score. The reliability for the subscores was good, but ICCs
were slightly lower because of the lowerpossible range inDI subscores
compared to the DI total score. This implies that the DI can be used to
assess separate joint groups, which is valuable for clinical trials.o the mean DI score. The solid line represents the mean difference between two raters,
Table IV
Correlation of the DI with AUSCAN and WOMAC expressed as Spearman’s rank
correlation coefﬁcient (95% CI) in 260 patients with OA at multiple sites
DI total DI hand DI knee/hip
AUSCAN pain 0.61 (0.53, 0.68) 0.65 (0.57, 0.72) e
AUSCAN function 0.62 (0.54, 0.69) 0.61 (0.53, 0.68) e
WOMAC pain 0.51 (0.42, 0.59) e 0.46 (0.36, 0.55)
WOMAC function 0.49 (0.39, 0.58) e 0.43 (0.33, 0.52)
For all values P< 0.01.
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clinical practice, especially the subscores for speciﬁc joint groups.
We have shown that it takes approximately 5 min to perform the
total DI. Performing only part of the DI takes less time and therefore
implementation in daily clinical practice seems realistic. Because of
its good clinimetric properties it can be a valuable measure since it
is more quantitative in nature than taking a pain history only.
We found a moderate level of correlation between AUSCAN and
WOMAC and the DI. This supports the idea that self-reported
outcomesmeasure other aspects of disease than physician obtained
outcomes. Our ﬁndings are in line with two studies assessing the
validity of the AUSCAN and WOMAC showing comparable or lower
levels of correlation with a modiﬁed DI10,16. In inﬂammatory
arthritis similar levels of correlation between self-reported and
clinically obtained outcome measures have been reported17,18.
There are some limitations to the present study. First, the study
was conducted in patients with familial OA at multiple sites. The
behaviour of the DI in other OA phenotypes may be different,
although pain is a shared symptom in all OA manifestations.
Secondly, the mean level of self-reported symptoms in this pop-
ulation seems to be low considering the Patient Acceptable
Symptom State (PASS)19. Assuming that self-reported symptoms
are related to pain on physical examination, this will result in
relatively low DI scores. We expect the inﬂuence on study outcome
to be minimal since ICCs and correlation coefﬁcients are more
dependent on the variability in measures20. We feel that the
variability in AUSCAN, WOMAC as well as DI scores in this study
population was sufﬁcient. Moreover, a higher mean level of
symptoms does not imply more variability in scores. Finally, it was
not possible to assess responsiveness to treatment, since this is an
observational study. Responsiveness is an important issue when
use in clinical trials is concerned. In the original DI paper this
feature was evaluated in a double-blind cross-over study3. It was
demonstrated that compared to treatment with a simple analgesic,
treatment with an anti-inﬂammatory agent resulted in a signiﬁcant
reduction of the DI score. No effect on self-reported pain was
observed, supporting that the DI has better features than self-
reported outcomes.
In conclusion, this study demonstrated that the DI is a reliable,
easy to perform, and valid measure of pain in OA. Its sensitivity to
change, evaluated previously in the GARP study, was higher than
established OA pain outcome measures. Because of these favorable
clinimetric properties and the idea that pain during physical
examination may reﬂect a different aspect of the disease, the DI
seems a valuable additional outcome measure not only for OA
research but also for clinical practice.
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